Antigen processing pathway in renal cell carcinoma implications for an immune escape mechanism

被引:0
|
作者
Atkins, D
Seliger, B
Ferrone, S
Störkel, S
机构
[1] Univ Witten Herdecke, Inst Pathol, Wuppertal, Germany
[2] Univ Mainz, Med Klin 3, Mainz, Germany
[3] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
583
引用
收藏
页码:101A / 101A
页数:1
相关论文
共 50 条
  • [41] Immune-related risk prognostic model for clear cell renal cell carcinoma: Implications for immunotherapy
    Chen, Ronghui
    Wu, Jun
    Liu, Shan
    Sun, Yefeng
    Liu, Guozhi
    Zhang, Lin
    Yu, Qing
    Xu, Juan
    Meng, Lingxin
    MEDICINE, 2023, 102 (34) : E34786
  • [42] Neoantigen Load, Antigen Presentation Machinery, and Immune Signatures Determine Prognosis in Clear Cell Renal Cell Carcinoma
    Matsushita, Hirokazu
    Sato, Yusuke
    Karasaki, Takahiro
    Nakagawa, Tohru
    Kume, Haruki
    Ogawa, Seishi
    Homma, Yukio
    Kakimi, Kazuhiro
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (05) : 463 - 471
  • [43] An Immune Atlas of Clear Cell Renal Cell Carcinoma
    Chevrier, Stephane
    Levine, Jacob Harrison
    Zanotelli, Vito Riccardo Tomaso
    Silina, Karina
    Schulz, Daniel
    Bacac, Marina
    Ries, Carola Hermine
    Ailles, Laurie
    Jewett, Michael Alexander Spencer
    Moch, Holger
    van den Broek, Maries
    Beisel, Christian
    Stadler, Michael Beda
    Gedye, Craig
    Reis, Bernhard
    Pe'er, Dana
    Bodenmiller, Bernd
    CELL, 2017, 169 (04) : 736 - 749
  • [44] Immune classification of clear cell renal cell carcinoma
    Sumeyye Su
    Shaya Akbarinejad
    Leili Shahriyari
    Scientific Reports, 11
  • [45] Immune classification of clear cell renal cell carcinoma
    Su, Sumeyye
    Akbarinejad, Shaya
    Shahriyari, Leili
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [46] Prosaposin hyperglycosylation: a novel tumor immune escape mechanism and implications for cancer immunotherapy
    Peipp, Matthias
    Dudziak, Diana
    Kellner, Christian
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [47] mTOR pathway inhibition in renal cell carcinoma
    Pinto Marin, Alvaro
    Redondo Sanchez, Andres
    Espinosa Arranz, Enrique
    Zamora Aunon, Pilar
    Castelo Fernandez, Beatriz
    Gonzalez Baron, Manuel
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (04) : 356 - 361
  • [48] Gene and immune therapy for renal cell carcinoma
    Pantuck, AJ
    Zisman, A
    Belldegrun, A
    INTERNATIONAL JOURNAL OF UROLOGY, 2001, 8 (07) : S1 - S4
  • [49] Immune checkpoint blockade in renal cell carcinoma
    Rappold, Phillip M.
    Silagy, Andrew W.
    Kotecha, Ritesh R.
    Hakimi, Ari A.
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (03) : 739 - 750
  • [50] The renal clear cell carcinoma immune landscape
    Saad, Omar A.
    Li, Wei Tse
    Krishnan, Aswini R.
    Nguyen, Griffith C.
    Lopez, Jay P.
    McKay, Rana R.
    Wang-Rodriguez, Jessica
    Ongkeko, Weg M.
    NEOPLASIA, 2022, 24 (02): : 145 - 154